Triple Antigen Vaccine

Product Details:

• Prescription only medicine.
• Keep out of reach of children.

• It is a vaccine indicated for active booster immunization against tetanus, diptheria, and pertussis.
• It is approved for use as a single dose in individuals 10 years of age and older.

• Severe allergic reaction after a previous dose of any tetanus toxoid-, diptheria toxoid-, or pertussis antigen-containing vaccine, or to any component of Boostrix, or encephalopathy within 7 days of a previous pertussis antigen-containing vaccine, is a contraindication.
• The tip caps of the prefilled syringes for Boostrix contain natural rubber latex, which may cause allergic reactions.
• The decision to give Boostrix should be based on benefits and risks if Guillain-Barre syndrome occurred within 6 weeks of receipt of a prior tetanus toxoid-containing vaccine.
• Syncope (fainting) can occur in association with administration of injectable vaccines. Procedures should be in place to avoid falling injury and to restore cerebral perfusion following syncope.
• Progressive or unstable neurologic conditions are reasons to defer vaccination with a pertussis-containing vaccine, including Boostrix.
• Persons who experienced an Arthus-type hypersensitivity reaction following a prior dose of tetanus toxoid-containing vaccine should not receive Boostrix unless 10 years have elapsed since the last dose of a tetanus toxoid-containing vaccine.
• In clinical studies, common adverse reactions were pain, redness, and swelling at the injection site, increase in arm circumference of injected arm, headache, fatigue, gastrointestinal symptoms, and fever.
• Vaccination with Boostrix may not result in protection in all vaccine recipients.

Product Details:

• It is a DTwP type of vaccine containing purified Diphtheria Toxoid, purified Tetanus toxoid and killed Bordetella pertussis bacilli.
• DTwP vaccine is administered to infants, above the age of 6 weeks and preschool children for active immunization against 3 diseases called Diptheria, Tetanus and Pertussis (Whooping cough) diseases.

• 3 primary doses of 0.5 ml should be given at 4-6 week interval.
• The first dose should be given at approximately 6 weeks of age.
• Booster dose of 0.5 ml should be given 12 months after the primary immunization and also between the ages of 4-6 years.